162 related articles for article (PubMed ID: 15569749)
1. Navigation-assisted sclerotherapy of orbital venolymphatic malformation: a new guidance technique for percutaneous treatment of low-flow vascular malformations.
Ernemann U; Westendorff C; Troitzsch D; Hoffmann J
AJNR Am J Neuroradiol; 2004; 25(10):1792-5. PubMed ID: 15569749
[TBL] [Abstract][Full Text] [Related]
2. Multimodality Image-Guided Sclerotherapy of Low-Flow Orbital Vascular Malformations: Report of Single-Center Experience.
Harmoush S; Chinnadurai P; El Salek K; Metwalli Z; Herce H; Bhatt A; Steinkuller P; Vece T; Siddiqui S; Pimpalwar A; Marx D; Mawad M; Pimpalwar S
J Vasc Interv Radiol; 2016 Jul; 27(7):987-995.e4. PubMed ID: 27184528
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit.
Chiramel GK; Keshava SN; Moses V; Mammen S; David S; Sen S
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):270-9. PubMed ID: 25148921
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin sclerotherapy of a distensible orbital venous malformation without image guidance.
Chen Y; Choi CJ; Lee BW
Can J Ophthalmol; 2019 Jun; 54(3):e120-e123. PubMed ID: 31109497
[No Abstract] [Full Text] [Related]
5. Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone.
Mustak H; Ugradar S; Goldberg R; Rootman D
Clin Exp Ophthalmol; 2018 Sep; 46(7):815-816. PubMed ID: 29369465
[No Abstract] [Full Text] [Related]
6. Sclerotherapy with intralesional bleomycin injection under guidance of multi-slice CT for retrobulbar orbital low-flow vascular lesions-single-center experience.
Lin SN; Wu YM; Siow TY; Yeh CH; Toh CH; Tseng TY; Wong HF
Br J Radiol; 2024 Jan; 97(1153):186-194. PubMed ID: 38263834
[TBL] [Abstract][Full Text] [Related]
7. Multimodality Management of Complex Periorbital Venolymphatic Malformations.
Ramesh S; Duckwiler G; Goldberg RA; Rootman DB
Ophthalmic Plast Reconstr Surg; 2019; 35(4):387-398. PubMed ID: 30601461
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: Systematic review and meta-analysis.
De Maria L; De Sanctis P; Tollefson M; Mardini S; Garrity JA; Morris PP; Bendel E; Brinjikji W
Surv Ophthalmol; 2020; 65(1):41-47. PubMed ID: 31425703
[TBL] [Abstract][Full Text] [Related]
9. Orbital vascular lesions. Role of imaging.
Bilaniuk LT
Radiol Clin North Am; 1999 Jan; 37(1):169-83, xi. PubMed ID: 10026736
[TBL] [Abstract][Full Text] [Related]
10. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome.
Boll DT; Merkle EM; Lewin JS
Radiology; 2004 Nov; 233(2):376-84. PubMed ID: 15516614
[TBL] [Abstract][Full Text] [Related]
11. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations.
Hanif AM; Saunders JA; Hawkins CM; Wojno TH; Kim HJ
Orbit; 2019 Feb; 38(1):30-36. PubMed ID: 29902086
[TBL] [Abstract][Full Text] [Related]
12. Orbital infarction syndrome after multiple percutaneous sclerotherapy sessions for facial low-flow vascular malformation: A case report and literature review.
Sio WS; Lee SH; Liang IC
Indian J Ophthalmol; 2016 Aug; 64(8):595-7. PubMed ID: 27688283
[TBL] [Abstract][Full Text] [Related]
13. MR-guided percutaneous sclerotherapy of low-flow vascular malformations: Clinical experience using a 1.5 tesla MR system.
O'Mara DM; DiCamillo PA; Gilson WD; Herzka DA; Wacker FK; Lewin JS; Weiss CR
J Magn Reson Imaging; 2017 Apr; 45(4):1154-1162. PubMed ID: 27796061
[TBL] [Abstract][Full Text] [Related]
14. Classification and treatment of orbital venous malformations: an updated review.
Li T; Jia R; Fan X
Front Med; 2019 Oct; 13(5):547-555. PubMed ID: 30097960
[TBL] [Abstract][Full Text] [Related]
15. Treatment of venous malformations--comparison to lymphatic malformations.
Schumacher M; Ernemann U; Berlis A; Weber J
Lymphology; 2008 Sep; 41(3):139-46. PubMed ID: 19013882
[TBL] [Abstract][Full Text] [Related]
16. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
Andreisek G; Nanz D; Weishaupt D; Pfammatter T
J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
[TBL] [Abstract][Full Text] [Related]
17. Orbital venous malformation: percutaneous treatment using an electrolytically detachable fibred coil.
Diolaiuti S; Iizuka T; Schroth G; Remonda L; Laedrach K; El-Koussy M; Frueh BE; Goldblum D
Acta Ophthalmol; 2009 Mar; 87(2):229-32. PubMed ID: 18547284
[TBL] [Abstract][Full Text] [Related]
18. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations.
Chen Y; Li Y; Zhu Q; Zeng Q; Zhao J; He X; Mei Q
AJR Am J Roentgenol; 2008 Apr; 190(4):966-71. PubMed ID: 18356443
[TBL] [Abstract][Full Text] [Related]
19. Transvenous sclerotherapy of a large symptomatic orbital venous varix using a microcatheter balloon and bleomycin.
Vadlamudi V; Gemmete JJ; Chaudhary N; Pandey AS; Kahana A
J Neurointerv Surg; 2016 Aug; 8(8):e30. PubMed ID: 26122325
[TBL] [Abstract][Full Text] [Related]
20. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
